LikeShareFollow
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiati
on into ready-to-transplant microtissues with unprecedented scalability and cell quality.
